Arkan Ventures Launches ESG-Focused Digital Health Roundtable Series

Arkan Ventures, a New York-based investment and advisory firm, is launching a groundbreaking Digital Health Roundtable Series in 2026, creating a structured forum for investors, practitioners, and innovators to examine technology's evolving role in healthcare delivery and financing. The invitation-based series will convene family offices, digital health operators, thematic specialists, and ESG-aligned allocators for facilitated discussions on capital deployment, sector trends, and structural conditions shaping care at scale. Each session will be grounded in Environmental, Social, and Governance (ESG) frameworks and aligned with specific United Nations Sustainable Development Goals—SDG 3 (Good Health and Well-being), SDG 9 (Industry, Innovation and Infrastructure), and SDG 17 (Partnerships for the Goals)—ensuring discussions remain anchored to measurable outcomes rather than broad aspirations.

The roundtable series, currently in development with first sessions anticipated for later in 2026, will follow a structured half-day format combining keynote perspectives from digital health operators or clinicians with facilitated investment dialogue. Thematic sessions under consideration include AI-assisted diagnostics and care delivery, interoperable health data and infrastructure, and financing equitable telehealth access in underserved communities. According to Chris Marcoux, Chief Communications Officer at Arkan Ventures, the initiative addresses a critical gap: "Family offices and impact-aligned investors frequently lack structured access to curated deal flow and peer-level dialogue in the digital health space." The firm is actively seeking digital health founders, healthcare investors, and subject-matter experts including clinicians, technologists, and policy practitioners to contribute perspectives and help shape the agenda across sessions.

Participants will engage with ESG measurement methodologies aligned to the SDG Impact Standards, providing a consistent framework through which healthcare allocations can be assessed for both financial and social performance. This innovative approach bridges the gap between traditional investment analysis and impact measurement, creating what could become a new standard for evaluating healthcare technology investments. The roundtable series represents a significant step toward more sophisticated, outcome-focused dialogue in the rapidly evolving digital health sector, potentially influencing how billions of dollars are allocated to healthcare innovation while ensuring those investments deliver both financial returns and meaningful social impact.